ImmuPharma (LON:IMM) Trading Down 15.6% – What’s Next?

ImmuPharma plc (LON:IMM)’s share price fell 15.6% during mid-day trading on Wednesday . The stock traded as low as GBX 4.60 ($0.06) and last traded at GBX 4.98 ($0.06). 68,204,375 shares were traded during mid-day trading, an increase of 164% from the average session volume of 25,820,418 shares. The stock had previously closed at GBX 5.90 ($0.07).

ImmuPharma Price Performance

The stock has a market cap of £20.74 million, a P/E ratio of -498.00 and a beta of 1.53. The company has a fifty day moving average of GBX 1.92 and a 200 day moving average of GBX 1.78.

ImmuPharma Company Profile

ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.